Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Cell
|
August 13, 1993
The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
F Grignani, P F Ferrucci, U Testa, et al.
Cancer Research
|
August 15, 1994
PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3
U Testa, F Grignani, T Barberi, et al.
Blood
|
April 1, 1995
Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia
L Flenghi, M Fagioli, L Tomassoni, et al.
Melanoma Research
|
March 10, 2015
Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study
Pier F Ferrucci, Ida Minchella, Massimo Mosconi, et al.
Oncogene
|
July 22, 1998
Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival
M Fagioli, M Alcalay, L Tomassoni, et al.
British Journal of Haematology
|
November 6, 2007
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas
Pier F Ferrucci, Anna Vanazzi, Chiara M Grana, et al.
Leukemia & Lymphoma
|
June 14, 2003
ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma
G Martinelli, P F Ferrucci, W Mingrone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2015
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab
S Valpione, C Martinoli, P Fava, et al.
Genes, Chromosomes & Cancer
|
June 13, 1998
In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes
M J Mozziconacci, C Liberatore, V Brunel, et al.
British Journal of Cancer
|
February 22, 2000
Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin
C Corsini, M Ghielmini, P Mancuso, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Cell
|
August 13, 1993
The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
F Grignani, P F Ferrucci, U Testa, et al.
Cancer Research
|
August 15, 1994
PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3
U Testa, F Grignani, T Barberi, et al.
Blood
|
April 1, 1995
Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia
L Flenghi, M Fagioli, L Tomassoni, et al.
Melanoma Research
|
March 10, 2015
Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study
Pier F Ferrucci, Ida Minchella, Massimo Mosconi, et al.
Oncogene
|
July 22, 1998
Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival
M Fagioli, M Alcalay, L Tomassoni, et al.
British Journal of Haematology
|
November 6, 2007
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas
Pier F Ferrucci, Anna Vanazzi, Chiara M Grana, et al.
Leukemia & Lymphoma
|
June 14, 2003
ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma
G Martinelli, P F Ferrucci, W Mingrone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2015
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab
S Valpione, C Martinoli, P Fava, et al.
Genes, Chromosomes & Cancer
|
June 13, 1998
In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes
M J Mozziconacci, C Liberatore, V Brunel, et al.
British Journal of Cancer
|
February 22, 2000
Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin
C Corsini, M Ghielmini, P Mancuso, et al.
Page
of 5